Quantumzyme (QTZM) EBIAT (2016 - 2026)
Quantumzyme (QTZM) has 6 years of EBIAT data on record, last reported at -$49868.0 in Q4 2025.
- For Q4 2025, EBIAT rose 23.89% year-over-year to -$49868.0; the TTM value through Oct 2025 reached -$141626.0, down 54.62%, while the annual FY2025 figure was -$199269.0, 11.59% down from the prior year.
- EBIAT reached -$49868.0 in Q4 2025 per QTZM's latest filing, up from -$65523.0 in the prior quarter.
- Across five years, EBIAT topped out at -$49868.0 in Q4 2025 and bottomed at -$65523.0 in Q4 2024.